Identification of a New Mechanism of Antithrombin Deficiency Hardly Detected by Current Methods: Duplication of SERPINC1 Exon 6

• References

• 1 Lijfering WM, Brouwer JL, Veeger NJ. , et al. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood 2009; 113 (21) 5314-5322
• 2 Mahmoodi BK, Brouwer JL, Ten Kate MK. , et al. A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin. J Thromb Haemost 2010; 8 (06) 1193-1200
• 3 Caspers M, Pavlova A, Driesen J. , et al. Deficiencies of antithrombin, protein C and protein S - practical experience in genetic analysis of a large patient cohort. Thromb Haemost 2012; 108 (02) 247-257
• 4 Luxembourg B, Delev D, Geisen C. , et al. Molecular basis of antithrombin deficiency. Thromb Haemost 2011; 105 (04) 635-646
• 5 Bayston TA, Lane DA. Antithrombin: molecular basis of deficiency. Thromb Haemost 1997; 78 (01) 339-343
• 6 de la Morena-Barrio ME, Martínez-Martínez I, de Cos C. , et al. Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect. J Thromb Haemost 2016; 14 (08) 1549-1560
• 7 Olds RJ, Lane DA, Chowdhury V, De Stefano V, Leone G, Thein SL. Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia. Biochemistry 1993; 32 (16) 4216-4224
• 8 Picard V, Chen JM, Tardy B. , et al. Detection and characterisation of large SERPINC1 deletions in type I inherited antithrombin deficiency. Hum Genet 2010; 127 (01) 45-53
• 9 Beauchamp NJ, Makris M, Preston FE, Peake IR, Daly ME. Major structural defects in the antithrombin gene in four families with type I antithrombin deficiency--partial/complete deletions and rearrangement of the antithrombin gene. Thromb Haemost 2000; 83 (05) 715-721
• 10 Jochmans K, Lissens W, Seneca S. , et al. The molecular basis of antithrombin deficiency in Belgian and Dutch families. Thromb Haemost 1998; 80 (03) 376-381
• 11 Lane DA, Bayston T, Olds RJ. , et al; For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Antithrombin mutation database: 2nd (1997) update. Thromb Haemost 1997; 77 (01) 197-211
• 12 Lee ST, Kim HJ, Kim DK, Schuit RJ, Kim SH. Detection of large deletion mutations in the SERPINC1 gene causing hereditary antithrombin deficiency by multiplex ligation-dependent probe amplification (MLPA). J Thromb Haemost 2008; 6 (04) 701-703
• 13 Pavlova A, El-Maarri O, Luxembourg B. , et al. Detection of heterozygous large deletions in the antithrombin gene using multiplex polymerase chain reaction and denatured high performance liquid chromatography. Haematologica 2006; 91 (09) 1264-1267
• 14 Cardoso AR, Oliveira M, Amorim A, Azevedo L. Major influence of repetitive elements on disease-associated copy number variants (CNVs). Hum Genomics 2016; 10 (01) 30
• 15 Lehrman MA, Goldstein JL, Russell DW, Brown MS. Duplication of seven exons in LDL receptor gene caused by Alu-Alu recombination in a subject with familial hypercholesterolemia. Cell 1987; 48 (05) 827-835
• 16 Hu XY, Ray PN, Worton RG. Mechanisms of tandem duplication in the Duchenne muscular dystrophy gene include both homologous and nonhomologous intrachromosomal recombination. EMBO J 1991; 10 (09) 2471-2477
• 17 Jurka J, Kohany O, Pavlicek A, Kapitonov VV, Jurka MV. Duplication, coclustering, and selection of human Alu retrotransposons. Proc Natl Acad Sci U S A 2004; 101 (05) 1268-1272